Gujarat Kidney And Super Speciality Limited (GKSL) — Board Meeting

1 Board Meeting 🟡 Notable Neutral 📄 PDF

📢 Key Event
Board approves 51% acquisition of Blue Tree Clinics LLC and appoints additional director

🔄 What Changed
Approved acquisition of 51% stake in Blue Tree Clinics LLC for Rs 19.83 crore and appointed Dr. Paresh Dhoti as additional non-executive director

🔮 What's Next
Appointment subject to shareholder approval at next AGM

💡 Investor Takeaway
The acquisition expands the company into UAE medical services and adds an independent director, potentially diversifying revenue streams.

Gujarat Kidney and Super Speciality Limited announced on July 9, 2026, that its board approved a 51% stake acquisition in UAE-based Blue Tree Clinics LLC via share purchase agreement, appointed Dr. Paresh Dhoti as an additional non-executive independent director, and initiated a postal ballot for IPO object variation. The acquisition involves a cash consideration of Rs 19.83 crore payable in two tranches, targeting a polyclinic specializing in plastic surgery, laser cosmetic, dental, and chiropractic services. The target reported Rs 3.14 crore net profit in FY2025. The appointment is subject to shareholder approval at the upcoming AGM.

2 Board Meeting 🟡 Notable Neutral 📄 PDF

📢 Key Event
Board approves Blue Tree Clinics acquisition and new director appointment

🔄 What Changed
Approved 51% stake purchase in Blue Tree Clinics LLC, appointed Dr. Paresh Dhoti as Additional Director, initiated postal ballot for IPO object variation

🔮 What's Next
Shareholder approval required for IPO object variation; acquisition completion within 50 days; appointment subject to AGM approval

💡 Investor Takeaway
The acquisition expands GKSL into UAE medical services while adding a new independent director to strengthen governance.

GKSL's board approved a 51% stake purchase in UAE's Blue Tree Clinics LLC via cash consideration of Rs 19.83 crore, appointed Dr. Paresh Dhoti as Additional Director, and initiated a shareholder vote for IPO object variation. The acquisition targets a Dubai medical clinic with Rs 10.54 crore AED revenue, while the new director brings 18 years of dental practice experience.

📊 Stock Analysis — GKSL ✨ Ask AI About This